FR2491334A1 - Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant - Google Patents

Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant Download PDF

Info

Publication number
FR2491334A1
FR2491334A1 FR8021292A FR8021292A FR2491334A1 FR 2491334 A1 FR2491334 A1 FR 2491334A1 FR 8021292 A FR8021292 A FR 8021292A FR 8021292 A FR8021292 A FR 8021292A FR 2491334 A1 FR2491334 A1 FR 2491334A1
Authority
FR
France
Prior art keywords
active substances
biologically active
trypsin
enzyme
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8021292A
Other languages
English (en)
French (fr)
Other versions
FR2491334B1 (enExample
Inventor
Pierre Jolles
Daniele Migliore-Samour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR8021292A priority Critical patent/FR2491334A1/fr
Priority to FR8118647A priority patent/FR2513881A2/fr
Priority to DE8181401537T priority patent/DE3162128D1/de
Priority to AT81401537T priority patent/ATE6032T1/de
Priority to EP81401537A priority patent/EP0049666B1/fr
Priority to PCT/FR1981/000126 priority patent/WO1982001131A1/fr
Priority to US06/385,645 priority patent/US4462990A/en
Publication of FR2491334A1 publication Critical patent/FR2491334A1/fr
Application granted granted Critical
Publication of FR2491334B1 publication Critical patent/FR2491334B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8021292A 1980-10-03 1980-10-03 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant Granted FR2491334A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR8021292A FR2491334A1 (fr) 1980-10-03 1980-10-03 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR8118647A FR2513881A2 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
DE8181401537T DE3162128D1 (en) 1980-10-03 1981-10-02 Biologically active compounds, their obtention from human casein and compositions containing them
AT81401537T ATE6032T1 (de) 1980-10-03 1981-10-02 Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
EP81401537A EP0049666B1 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention à partir de caséine humaine et compositions les contenant
PCT/FR1981/000126 WO1982001131A1 (fr) 1980-10-03 1981-10-02 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
US06/385,645 US4462990A (en) 1980-10-03 1981-10-02 Biologically active substances, their obtainment from human casein and compositions containing said substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8021292A FR2491334A1 (fr) 1980-10-03 1980-10-03 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2491334A1 true FR2491334A1 (fr) 1982-04-09
FR2491334B1 FR2491334B1 (enExample) 1983-09-23

Family

ID=9246554

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8021292A Granted FR2491334A1 (fr) 1980-10-03 1980-10-03 Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Country Status (6)

Country Link
US (1) US4462990A (enExample)
EP (1) EP0049666B1 (enExample)
AT (1) ATE6032T1 (enExample)
DE (1) DE3162128D1 (enExample)
FR (1) FR2491334A1 (enExample)
WO (1) WO1982001131A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565985A1 (fr) * 1984-06-19 1985-12-20 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298493A (en) * 1983-04-20 1994-03-29 Clintec Nutrition Co. Compound for use in dietetics, reanimation and therapeutics containing protein fractions based on three types of minipeptides
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
FR2559157B1 (fr) * 1984-02-07 1986-08-01 Inst Nat Sante Rech Med Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
FR2565984B1 (fr) * 1984-06-19 1986-08-29 Rhone Poulenc Sante Nouvelles substances biologiquement actives, leur procede de preparation a partir du fibrinogene bovin et les compositions qui les contiennent
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
EP0218900B1 (en) * 1985-09-10 1992-01-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis
JPH0680014B2 (ja) * 1985-12-10 1994-10-12 雪印乳業株式会社 低分子ペプチドを有効成分とする免疫賦活剤及びその調製法
FR2594847B1 (fr) * 1986-02-25 1989-06-02 Moet Hennessy Rech Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5344820A (en) * 1987-05-15 1994-09-06 Snow Brand Milk Products Co., Ltd. Infection protectant
SE465109B (sv) * 1989-10-30 1991-07-29 Bengt Andersson Antibakteriell komposition
US5290685A (en) * 1990-02-22 1994-03-01 Meiji Milk Products Company Limited Method for separation and concentration of phosphopeptides
FR2688005B1 (fr) * 1992-02-28 1995-10-20 Montpellier Ii Universite Moyens pour le controle de produits renfermant des proteines laitieres.
AU693544B2 (en) * 1994-04-19 1998-07-02 Kanebo Seiyaku, Ltd. Preventive for circulatory diseases
AU2003299568B2 (en) 2002-11-27 2010-07-22 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
JP4427541B2 (ja) * 2004-03-05 2010-03-10 プリマハム株式会社 乳アレルゲンの検出方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1466141A (fr) * 1966-01-31 1967-01-13 Nouvelles substances biologiques destinées à la préparation de compositions détergentes à usage corporel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1631887A (en) * 1927-06-07 Sigwok to society of chemical indttstby in basle
US1658289A (en) * 1921-01-31 1928-02-07 Heidlberg Fritz Protective colloid and process of preparing the ame
US3186918A (en) * 1962-07-20 1965-06-01 Borden Co Low viscosity casein
US3323929A (en) * 1962-07-20 1967-06-06 Borden Co Low viscosity casein
FR1411478A (fr) * 1964-10-14 1965-09-17 Nouvelle composition destinée à la protection de la peau contre l'agressivité dessolvants et substances hydrophobes variées
FR1461423A (fr) * 1965-06-22 1966-02-25 Nouvelle composition biologique destinée aux soins hygiéniques et esthétiques de la peau humaine
NL132126C (enExample) * 1966-10-13
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
FR2422400A1 (fr) * 1978-04-13 1979-11-09 Morelle Jean Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1466141A (fr) * 1966-01-31 1967-01-13 Nouvelles substances biologiques destinées à la préparation de compositions détergentes à usage corporel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565985A1 (fr) * 1984-06-19 1985-12-20 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
EP0170550A1 (fr) * 1984-06-19 1986-02-05 Rhone-Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procédé de preparation et les compositions qui les contiennent
US4777243A (en) * 1984-06-19 1988-10-11 Rhone Poulenc Sante, French Body Corporate Immuno stimulant substances derived from bovine casein and compositions containing the same

Also Published As

Publication number Publication date
EP0049666B1 (fr) 1984-02-01
US4462990A (en) 1984-07-31
EP0049666A1 (fr) 1982-04-14
DE3162128D1 (en) 1984-03-08
FR2491334B1 (enExample) 1983-09-23
ATE6032T1 (de) 1984-02-15
WO1982001131A1 (fr) 1982-04-15

Similar Documents

Publication Publication Date Title
FR2491334A1 (fr) Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
BE1001630A4 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques.
FR2596990A1 (fr) Adjuvant immunologique a base d'emulsion de lipide et d'un adjuvant bacterien
FR2620941A1 (fr) Vaccin contenant des adjuvants et des antigenes tumoraux
EP0170550B1 (fr) Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procédé de preparation et les compositions qui les contiennent
FR2682388A1 (fr) Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
EP0015810A1 (fr) N-acétyl-L-(N-méthyl-alanyl)-D-isoglutamine et compositions la contenat, pour l'utilisation en tant que régulateurs des mécanismes immunitaires
EP0001945A1 (fr) Nouveaux polysaccharides extraits de corps microbiens d'Haemophilus Influenzae, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0071515B1 (fr) Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins
EP0165123B1 (fr) Dérivés lipophiles de muramylpeptides ayant des propriétés d'activation des macrophages, compositions les contenant et procédé pour les obtenir
KR920002935B1 (ko) 맥관 형성 저해제
FR2487195A1 (fr) Procede et composition permettant d'abaisser le taux de cholesterol contenu dans le sang
EP0006068B1 (fr) Composés du type muramyl-peptide et médicaments les contenant
IL165970A (en) Method of isolating biologically active fraction containing clinically acceptable native s-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
CA1250810A (fr) Hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
EP0149581B1 (fr) Nouvelles compositions contenant des oligo-muramylpeptides et leur application, notamment pour l'activation des macrophages
BE1004569A3 (fr) Exopolymere extracellulaire, son procede de preparation et compositions pharmaceutiques le contenant.
EP0169115A1 (fr) Nouvelles substances immunologiquement actives, leur procédé de préparation à partir du fibrinogène bovin et les compositions qui les contiennent
JP2892300B2 (ja) Ｈｓｐ４７合成抑制剤
FR2513881A2 (fr) Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2834292A1 (fr) Extraits bacteriens de sangsues a effet notamment thrombolytique
FR2532850A1 (fr) Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention
FR2466247A1 (fr) Preparation immuno-stimulante et application
EP0316212B1 (fr) Application de nitrophényles ou d'anticorps anti-nitrophényles à la modification de l'interaction entre des cellules sensibles d'un hôte et un agent pathogene
FR2692148A1 (fr) Composition adjuvante de l'immunité humorale et à médiation cellulaire n'induisant pas de réponse vis-à-vis de déterminants auto-antigéniques.

Legal Events

Date Code Title Description
ST Notification of lapse